GNH USA

Europe — EMA

Iopamiro

GNH USA supplies Iopamiro (Iopamidol), a iodinated contrast media for vascular imaging, CT scans and myelography. Request a quote for global supply today.

Iopamidol

Request sourcing

1
Pack/s

What is Iopamidol?

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a sterile injectable solution for intra‑arterial, intrathecal, and intravenous use. It provides high‑density radiographic contrast that improves visualization of vascular structures, soft tissues, and the spinal canal during angiography, computed tomography (CT) scans, and myelography procedures.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and imaging centers worldwide, and research institutions, ensuring reliable access to quality contrast media for diagnostic imaging.

What is Iopamidol used for?

Iopamiro, an iodinated contrast medium, is used in diagnostic imaging to enhance visualization of vascular and tissue structures.

- Vascular imaging (angiography): provides enhanced contrast of blood vessels for detailed angiographic assessment. - Computed tomography (CT) scans: improves tissue differentiation and organ delineation during CT imaging. - Myelography: outlines the spinal canal and nerve roots for clearer myelographic studies.

What are the side effects of Iopamidol?

Iopamiro may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Warm sensation or flushing at injection site - Metallic taste or mild nausea - Headache - Transient dizziness

Serious or Rare Side Effects: - Severe allergic or anaphylactoid reaction - Acute renal impairment - Seizures or neurologic disturbances - Cardiovascular collapse

What precautions apply to Iopamidol?

Before administering Iopamiro, several precautions should be observed. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Review allergy history: identify prior reactions to iodinated contrast agents. - Use lowest effective dose: tailor volume to patient size and imaging requirement. - Monitor for hypersensitivity: observe patient during and after injection for signs of reaction. - Avoid in severe iodine allergy: contraindicated in patients with known severe hypersensitivity to iodine. - Store at ambient temperature: keep below 25 °C in original packaging, protect from light and moisture.

What does Iopamidol interact with?

Iopamiro can interact with certain medications and substances.

Major Interactions (Avoid): - Concurrent use of other high‑osmolality iodinated contrast agents: increase risk of toxicity. - Metformin in patients with impaired renal function: risk of lactic acidosis. - Aminoglycoside antibiotics in renal‑compromised patients: additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., furosemide): may affect renal clearance of contrast. - ACE inhibitors or ARBs: monitor renal function and electrolytes. - NSAIDs: potential for reduced renal perfusion. - Thyroid hormone replacement: iodine load may affect thyroid function tests.

Frequently asked questions

What is Iopamiro used for?+
Iopamiro is a sterile iodinated contrast medium containing iopamidol, employed in diagnostic imaging procedures such as angiography, computed tomography (CT) scans, and myelography to enhance visualization of vascular structures and tissues.
How does iopamidol work?+
Iopamidol provides radiographic contrast by delivering a high concentration of iodine atoms that absorb X‑ray photons, increasing attenuation of the beam in the administered area. This creates a difference in radiodensity between contrast‑filled vessels or spaces and surrounding tissues, allowing clearer imaging.
What is the usual dose of Iopamiro?+
The dose of Iopamiro is individualized by the prescribing physician based on the specific imaging study, patient size, renal function, and the required level of contrast enhancement. The healthcare professional determines the appropriate volume and concentration for each procedure.
Is Iopamiro safe in pregnancy or breastfeeding?+
The safety of Iopamiro during pregnancy or lactation has not been definitively established. It should be used only if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician in consultation with the patient.
How do I order Iopamiro from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.
How does Iopamiro compare with other iodinated contrast agents?+
Iopamiro contains iopamidol, a non‑ionic, low‑osmolality iodinated contrast medium, which generally offers a lower incidence of discomfort and adverse reactions compared with older high‑osmolality agents. Its imaging performance is comparable to other low‑osmolality agents, while providing good vascular and tissue enhancement for angiography, CT and myelography.
How should I store Iopamiro?+
Iopamiro should be stored at controlled room temperature, below 25 °C, in its original packaging to protect it from light and moisture. Do not freeze the product, and keep it out of reach of children. Verify the expiry date before use.
How is Iopamiro administered?+
Iopamiro is administered by a qualified healthcare professional via intra‑arterial, intravenous or intrathecal injection, depending on the imaging procedure. The injection is typically performed using a sterile technique, and the volume and rate are adjusted according to the specific diagnostic requirement and patient factors.
What are the most serious risks associated with Iopamiro?+
The most serious risks include severe allergic or anaphylactoid reactions, renal toxicity especially in patients with pre‑existing kidney impairment, and rare neurologic events such as seizures. Prompt recognition and management of these reactions are essential, and patients should be monitored closely during and after administration.
Who should not receive Iopamiro?+
Iopamiro should be avoided in patients with a known hypersensitivity to iopamidol or any iodinated contrast media, those with severe renal insufficiency where alternative imaging is possible, and individuals with a history of severe iodine‑related allergic reactions. The prescribing clinician must assess each patient’s risk before use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Iopamidol
Route
Intraarterial Use , Intrathecal Use , Intravenous
Manufacturer
Bracco Imaging S.P.A.
Origin
EU

Related products